ID

44019

Descrição

SMILDA - Symbicort®Turbuhaler® Allergan Challenge Study in Allergic Patients With Mild Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT00288379

Link

https://clinicaltrials.gov/show/NCT00288379

Palavras-chave

  1. 07/04/2016 07/04/2016 -
  2. 20/09/2021 20/09/2021 -
Titular dos direitos

CC BY-NC 3.0

Transferido a

20 de setembro de 2021

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :


    Sem comentários

    Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

    Eligibility Asthma NCT00288379

    Eligibility Asthma NCT00288379

    1. StudyEvent: Eligibility
      1. Eligibility Asthma NCT00288379
    Inclusion Criteria
    Descrição

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    a diagnosed history of asthma for at least 6 months
    Descrição

    asthma

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1,1]
    C0004096
    UMLS CUI [1,2]
    C0040223
    mild and stable asthma, only using β2-agonists as needed for the last 4 weeks.
    Descrição

    mild stable asthma only using β2-agonists

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1,1]
    C0741266
    UMLS CUI [1,2]
    C2945599
    UMLS CUI [2]
    C2936789
    fev1 >70% of predicted normal value (post-bronchodilator value).
    Descrição

    fev1 post-bronchodilator

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1,1]
    C0748133
    UMLS CUI [1,2]
    C2599594
    skin prick test positive to pollen, animal dander or house dust mite.
    Descrição

    skin prick test positive to pollen, animal dander or house dust mite

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1,1]
    C0430561
    UMLS CUI [1,2]
    C0323138
    UMLS CUI [1,3]
    C0440454
    UMLS CUI [1,4]
    C3539110
    Exclusion Criteria
    Descrição

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    any significant respiratory disease, other than asthma.
    Descrição

    respiratory disease

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0035204
    upper or lower respiratory tract infection within 4 weeks before inclusion.
    Descrição

    respiratory tract infection

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1,1]
    C0035243
    UMLS CUI [1,2]
    C0040223
    use of:
    Descrição

    use of

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C1524063
    1. inhaled glucocorticosteroid treatment for the last 8 weeks prior to inclusion or ever used oral glucocorticoid treatment for asthma.
    Descrição

    inhaled steroid treatment

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1,1]
    C0001617
    UMLS CUI [1,2]
    C0556393
    UMLS CUI [1,3]
    C0006280
    UMLS CUI [1,4]
    C0040223
    2. inhaled long-acting or oral b2-agonists, anticholinergic bronchodilators, cromones, antihistamines, theophyllines and anti-leukotrienes within 2 weeks of screening.
    Descrição

    inhaled long-acting or oral b2-agonists, anticholinergic bronchodilators, cromones, antihistamines, theophyllines and anti-leukotrienes

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C2936789
    UMLS CUI [2]
    C0354764
    UMLS CUI [3]
    C0019590
    UMLS CUI [4]
    C0039771
    3. regular nsaids
    Descrição

    nsaids

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0003211

    Similar models

    Eligibility Asthma NCT00288379

    1. StudyEvent: Eligibility
      1. Eligibility Asthma NCT00288379
    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de dados
    Alias
    Item Group
    C1512693 (UMLS CUI)
    asthma
    Item
    a diagnosed history of asthma for at least 6 months
    boolean
    C0004096 (UMLS CUI [1,1])
    C0040223 (UMLS CUI [1,2])
    mild stable asthma only using β2-agonists
    Item
    mild and stable asthma, only using β2-agonists as needed for the last 4 weeks.
    boolean
    C0741266 (UMLS CUI [1,1])
    C2945599 (UMLS CUI [1,2])
    C2936789 (UMLS CUI [2])
    fev1 post-bronchodilator
    Item
    fev1 >70% of predicted normal value (post-bronchodilator value).
    boolean
    C0748133 (UMLS CUI [1,1])
    C2599594 (UMLS CUI [1,2])
    skin prick test positive to pollen, animal dander or house dust mite
    Item
    skin prick test positive to pollen, animal dander or house dust mite.
    boolean
    C0430561 (UMLS CUI [1,1])
    C0323138 (UMLS CUI [1,2])
    C0440454 (UMLS CUI [1,3])
    C3539110 (UMLS CUI [1,4])
    Item Group
    C0680251 (UMLS CUI)
    respiratory disease
    Item
    any significant respiratory disease, other than asthma.
    boolean
    C0035204 (UMLS CUI [1])
    respiratory tract infection
    Item
    upper or lower respiratory tract infection within 4 weeks before inclusion.
    boolean
    C0035243 (UMLS CUI [1,1])
    C0040223 (UMLS CUI [1,2])
    use of
    Item
    use of:
    boolean
    C1524063 (UMLS CUI [1])
    inhaled steroid treatment
    Item
    1. inhaled glucocorticosteroid treatment for the last 8 weeks prior to inclusion or ever used oral glucocorticoid treatment for asthma.
    boolean
    C0001617 (UMLS CUI [1,1])
    C0556393 (UMLS CUI [1,2])
    C0006280 (UMLS CUI [1,3])
    C0040223 (UMLS CUI [1,4])
    inhaled long-acting or oral b2-agonists, anticholinergic bronchodilators, cromones, antihistamines, theophyllines and anti-leukotrienes
    Item
    2. inhaled long-acting or oral b2-agonists, anticholinergic bronchodilators, cromones, antihistamines, theophyllines and anti-leukotrienes within 2 weeks of screening.
    boolean
    C2936789 (UMLS CUI [1])
    C0354764 (UMLS CUI [2])
    C0019590 (UMLS CUI [3])
    C0039771 (UMLS CUI [4])
    nsaids
    Item
    3. regular nsaids
    boolean
    C0003211 (UMLS CUI [1])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial